Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Phlebotonics for haemorrhoids.

Identifieur interne : 004020 ( Main/Exploration ); précédent : 004019; suivant : 004021

Phlebotonics for haemorrhoids.

Auteurs : Nirmal Perera [Royaume-Uni] ; Danae Liolitsa ; Satheesh Iype ; Anna Croxford ; Muhammed Yassin ; Peter Lang ; Obioha Ukaegbu ; Christopher Van Issum

Source :

RBID : pubmed:22895941

Descripteurs français

English descriptors

Abstract

Haemorrhoids are variceal dilatations of the anal and perianal venous plexus and often develop secondary to the persistently elevated venous pressure within the haemorrhoidal plexus (Kumar 2005). Phlebotonics are a heterogenous class of drugs consisting of plant extracts (i.e. flavonoids) and synthetic compounds (i.e. calcium dobesilate). Although their precise mechanism of action has not been fully established, they are known to improve venous tone, stabilize capillary permeability and increase lymphatic drainage. They have been used to treat a variety of conditions including chronic venous insufficiency, lymphoedema and haemorrhoids.Numerous trials assessing the effect of phlebotonics in treating the symptoms and signs of haemorrhoidal disease suggest that there is a potential benefit.

DOI: 10.1002/14651858.CD004322.pub3
PubMed: 22895941


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Phlebotonics for haemorrhoids.</title>
<author>
<name sortKey="Perera, Nirmal" sort="Perera, Nirmal" uniqKey="Perera N" first="Nirmal" last="Perera">Nirmal Perera</name>
<affiliation wicri:level="1">
<nlm:affiliation>General Medicine, Addenbrookes Hospital, Cambridge, UK. perera.nirmal@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>General Medicine, Addenbrookes Hospital, Cambridge</wicri:regionArea>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Liolitsa, Danae" sort="Liolitsa, Danae" uniqKey="Liolitsa D" first="Danae" last="Liolitsa">Danae Liolitsa</name>
</author>
<author>
<name sortKey="Iype, Satheesh" sort="Iype, Satheesh" uniqKey="Iype S" first="Satheesh" last="Iype">Satheesh Iype</name>
</author>
<author>
<name sortKey="Croxford, Anna" sort="Croxford, Anna" uniqKey="Croxford A" first="Anna" last="Croxford">Anna Croxford</name>
</author>
<author>
<name sortKey="Yassin, Muhammed" sort="Yassin, Muhammed" uniqKey="Yassin M" first="Muhammed" last="Yassin">Muhammed Yassin</name>
</author>
<author>
<name sortKey="Lang, Peter" sort="Lang, Peter" uniqKey="Lang P" first="Peter" last="Lang">Peter Lang</name>
</author>
<author>
<name sortKey="Ukaegbu, Obioha" sort="Ukaegbu, Obioha" uniqKey="Ukaegbu O" first="Obioha" last="Ukaegbu">Obioha Ukaegbu</name>
</author>
<author>
<name sortKey="Van Issum, Christopher" sort="Van Issum, Christopher" uniqKey="Van Issum C" first="Christopher" last="Van Issum">Christopher Van Issum</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22895941</idno>
<idno type="pmid">22895941</idno>
<idno type="doi">10.1002/14651858.CD004322.pub3</idno>
<idno type="wicri:Area/PubMed/Corpus">001F98</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F98</idno>
<idno type="wicri:Area/PubMed/Curation">001F98</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001F98</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001F98</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001F98</idno>
<idno type="wicri:Area/Ncbi/Merge">005043</idno>
<idno type="wicri:Area/Ncbi/Curation">005043</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005043</idno>
<idno type="wicri:Area/Main/Merge">004034</idno>
<idno type="wicri:Area/Main/Curation">004020</idno>
<idno type="wicri:Area/Main/Exploration">004020</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Phlebotonics for haemorrhoids.</title>
<author>
<name sortKey="Perera, Nirmal" sort="Perera, Nirmal" uniqKey="Perera N" first="Nirmal" last="Perera">Nirmal Perera</name>
<affiliation wicri:level="1">
<nlm:affiliation>General Medicine, Addenbrookes Hospital, Cambridge, UK. perera.nirmal@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>General Medicine, Addenbrookes Hospital, Cambridge</wicri:regionArea>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Liolitsa, Danae" sort="Liolitsa, Danae" uniqKey="Liolitsa D" first="Danae" last="Liolitsa">Danae Liolitsa</name>
</author>
<author>
<name sortKey="Iype, Satheesh" sort="Iype, Satheesh" uniqKey="Iype S" first="Satheesh" last="Iype">Satheesh Iype</name>
</author>
<author>
<name sortKey="Croxford, Anna" sort="Croxford, Anna" uniqKey="Croxford A" first="Anna" last="Croxford">Anna Croxford</name>
</author>
<author>
<name sortKey="Yassin, Muhammed" sort="Yassin, Muhammed" uniqKey="Yassin M" first="Muhammed" last="Yassin">Muhammed Yassin</name>
</author>
<author>
<name sortKey="Lang, Peter" sort="Lang, Peter" uniqKey="Lang P" first="Peter" last="Lang">Peter Lang</name>
</author>
<author>
<name sortKey="Ukaegbu, Obioha" sort="Ukaegbu, Obioha" uniqKey="Ukaegbu O" first="Obioha" last="Ukaegbu">Obioha Ukaegbu</name>
</author>
<author>
<name sortKey="Van Issum, Christopher" sort="Van Issum, Christopher" uniqKey="Van Issum C" first="Christopher" last="Van Issum">Christopher Van Issum</name>
</author>
</analytic>
<series>
<title level="j">The Cochrane database of systematic reviews</title>
<idno type="eISSN">1469-493X</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Calcium Dobesilate (therapeutic use)</term>
<term>Diosmin (therapeutic use)</term>
<term>Flavonoids (therapeutic use)</term>
<term>Hemorrhoids (therapy)</term>
<term>Hemostatics (therapeutic use)</term>
<term>Humans</term>
<term>Hydroxyethylrutoside (analogs & derivatives)</term>
<term>Hydroxyethylrutoside (therapeutic use)</term>
<term>Ligation (methods)</term>
<term>Postoperative Care</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Vasoconstrictor Agents (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Diosmine (usage thérapeutique)</term>
<term>Dobésilate de calcium (usage thérapeutique)</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Flavonoïdes (usage thérapeutique)</term>
<term>Humains</term>
<term>Hémorroïdes ()</term>
<term>Hémostatiques (usage thérapeutique)</term>
<term>Ligature ()</term>
<term>O-(bêta-Hydroxyéthyl)rutosides (analogues et dérivés)</term>
<term>O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique)</term>
<term>Soins postopératoires</term>
<term>Vasoconstricteurs (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Hydroxyethylrutoside</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Calcium Dobesilate</term>
<term>Diosmin</term>
<term>Flavonoids</term>
<term>Hemostatics</term>
<term>Hydroxyethylrutoside</term>
<term>Vasoconstrictor Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>O-(bêta-Hydroxyéthyl)rutosides</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Ligation</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Hemorrhoids</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Diosmine</term>
<term>Dobésilate de calcium</term>
<term>Flavonoïdes</term>
<term>Hémostatiques</term>
<term>O-(bêta-Hydroxyéthyl)rutosides</term>
<term>Vasoconstricteurs</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Postoperative Care</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Essais contrôlés randomisés comme sujet</term>
<term>Humains</term>
<term>Hémorroïdes</term>
<term>Ligature</term>
<term>Soins postopératoires</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Haemorrhoids are variceal dilatations of the anal and perianal venous plexus and often develop secondary to the persistently elevated venous pressure within the haemorrhoidal plexus (Kumar 2005). Phlebotonics are a heterogenous class of drugs consisting of plant extracts (i.e. flavonoids) and synthetic compounds (i.e. calcium dobesilate). Although their precise mechanism of action has not been fully established, they are known to improve venous tone, stabilize capillary permeability and increase lymphatic drainage. They have been used to treat a variety of conditions including chronic venous insufficiency, lymphoedema and haemorrhoids.Numerous trials assessing the effect of phlebotonics in treating the symptoms and signs of haemorrhoidal disease suggest that there is a potential benefit.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Croxford, Anna" sort="Croxford, Anna" uniqKey="Croxford A" first="Anna" last="Croxford">Anna Croxford</name>
<name sortKey="Iype, Satheesh" sort="Iype, Satheesh" uniqKey="Iype S" first="Satheesh" last="Iype">Satheesh Iype</name>
<name sortKey="Lang, Peter" sort="Lang, Peter" uniqKey="Lang P" first="Peter" last="Lang">Peter Lang</name>
<name sortKey="Liolitsa, Danae" sort="Liolitsa, Danae" uniqKey="Liolitsa D" first="Danae" last="Liolitsa">Danae Liolitsa</name>
<name sortKey="Ukaegbu, Obioha" sort="Ukaegbu, Obioha" uniqKey="Ukaegbu O" first="Obioha" last="Ukaegbu">Obioha Ukaegbu</name>
<name sortKey="Van Issum, Christopher" sort="Van Issum, Christopher" uniqKey="Van Issum C" first="Christopher" last="Van Issum">Christopher Van Issum</name>
<name sortKey="Yassin, Muhammed" sort="Yassin, Muhammed" uniqKey="Yassin M" first="Muhammed" last="Yassin">Muhammed Yassin</name>
</noCountry>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Perera, Nirmal" sort="Perera, Nirmal" uniqKey="Perera N" first="Nirmal" last="Perera">Nirmal Perera</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004020 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004020 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:22895941
   |texte=   Phlebotonics for haemorrhoids.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22895941" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024